The shifting landscape of safety pharmacology in 2015

Journal of Pharmacological and Toxicological Methods

Volumn 75, Issue , 2015, Pages 5-9

  Pugsley, Michael K ^a   Authier, Simon ^a   Stonerook, Michael ^b   Curtis, Michael J ^c  

^a SOLVO BIOTECHNOLOGY   (Hungary)

^b Cardiovascular Division Rayne Institute St Thomas' Hospital ^*  (United States)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR PROCEDURE; CENTRAL NERVOUS SYSTEM FUNCTION; CERTIFICATION; COMPUTER MODEL; DRUG SAFETY; EDITORIAL; HEALTH CARE SURVEY; HUMAN; NEPHROTOXICITY; NONHUMAN; PHARMACOLOGY; PUBLICATION; PUBLISHING; STEM CELL; ADVERSE DRUG REACTION; ANIMAL; ORGANIZATION AND MANAGEMENT; PRECLINICAL STUDY; PROCEDURES; THEORETICAL MODEL; TOXICOLOGY;

ANIMALS; DRUG EVALUATION, PRECLINICAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; MODELS, THEORETICAL; PHARMACOLOGY; TOXICOLOGY;

EID: 84942366358     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2015.05.013     Document Type: Editorial

References (36)

1. Abernathy M.M., Gauvin D.V., Tapp R.L., Yoder J.D., Baird T.J. Utility of the Auditory Brainstem Response evaluation in non-clinical drug safety evaluations. Journal of Pharmacological and Toxicological Methods 2015, 75:111-117.
2. Asakura K., Hayashi S., Ojima A., Taniguchi T., Miyamoto N., Nakamori C., et al. Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes. Journal of Pharmacological and Toxicological Methods 2015, 75:17-26.
3. Authier S., Curtis M.J., Soloviev M., Redfern W.S., Kallman M.J., Hamlin R.L., et al. The Diplomate in Safety Pharmacology (DSP) certification scheme. Journal of Pharmacological and Toxicological Methods 2015, 75:1-4.
4. Benjamin A., Gallacher D.J., Greiter-Wilke A., Guillon J.M., Kasai C., Ledieu D., et al. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies. Journal of Pharmacological and Toxicological Methods 2015, 75:101-110.
5. Cary R., Clarke S., Delic J. Effects of combined exposure to noise and toxic substances-Critical review of the literature. Annals of Occupational Hygiene 1997, 41:455-465.
6. Gauvin D.V., Dalton J.A., Baird T.J. Extended recording of rat locomotor activity in closed photobeam chambers: Effects on activity and arterial blood gases. Journal of Pharmacological and Toxicological Methods 2015, (in press).
7. Gauvin D.V., McComb M., Code R., Dalton J.A., Baird T.J. Abuse liability assessment of hydrocodone under current draft regulatory guidelines. Journal of Pharmacological and Toxicological Methods 2015, 75:118-129.
8. Gibson J.K., Yue Y., Bronson J., Palmer C., Numann R. Adult human stem cell-derived cardiomyocytes detect drug-mediated changes on action potentials. Journal of Pharmacological and Toxicological Methods 2014, 70:255-267.
9. Gilbert L.M., Sgro M.P., Modlin L.M., Wheat N.J., Kallman M.J. Improvements in self-administration studies based on changes in skin button type and surgical technique. Journal of Pharmacological and Toxicological Methods 2015, 75:130-134.
10. Grandi E., Pasqualini F.S., Bers D.M. A novel computational model of the human ventricular action potential and Ca transient. Journal of Molecular and Cellular Cardiology 2010, 48:112-121.
11. Guth B.D., Chiang A.Y., Doyle J., Engwall M.J., Guillon J.M., Hoffmann P., et al. The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortium. Journal of Pharmacological and Toxicological Methods 2015, 75:70-90.
12. Kaiser R.A., Tichenor S.D., Regalia D.E., York K., Holzgrefe H.H. Telemetric assessment of social and single housing: Evaluation of electrocardiographic intervals in jacketed cynomolgus monkeys. Journal of Pharmacological and Toxicological Methods 2015, 75:38-43.
13. Klumpp A., Trautmann T., Markert M., Guth B. Optimizing the experimental environment for dog telemetry studies. Journal of Pharmacological and Toxicological Methods 2006, 54:141-149.
14. Kremer J.J., Bills A.J., Hanke N., Chena H., Meiera W., Osinski M.A., et al. Evaluation of cardiovascular changes in dogs administered three positive controls using Jacketed External Telemetry-Blood Pressure (JET-BP). Journal of Pharmacological and Toxicological Methods 2015, 75:27-37.
15. Metea M., Litwak M., Arrezzo J.A. Assessment of seizure risk in pre-clinical studies: Strengths and limitations of the electroencephalogram (EEG). Journal of Pharmacological and Toxicological Methods 2015, 75:135-142.
16. Morrissette P., Regan H.K., Fitzgerald K., Bernasconi S., Gerenser P., Travis P., et al. QT Interval correction assessment on the anesthetized guinea pig. Journal of Pharmacological and Toxicological Methods 2015, 75:52-61.
17. Ocampo J.A. Report of the International Narcotics Control Board for 2008 2009, United Nations Publications, New York.
18. O'Hara T., Virág L., Varró A., Rudy Y. Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Computational Biology 2011, 7(5):e1002061. 10.1371/journal.pcbi.1002061.
19. Paci M., Hyttinen J., Aalto-Setala K., Severi S. Computational models of ventricular and atrial-like human induced pluripotent stem cell derived cardiomyocytes. Annals of Biomedical Engineering 2013, 41:2334-2348.
20. Peng S., Lacerda A.E., Kirsch G.E., Brown A.M., Bruening-Wright A. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. Journal of Pharmacological and Toxicological Methods 2010, 61:277-286.
21. Pierson J.B., Berridge B.R., Brooks M.B., Dreher K., Koerner J., Schultze A.E., et al. A public-private consortium advances cardiac safety evaluation: achievements of the HESI Cardiac Safety Technical Committee. Journal of Pharmacological and Toxicological Methods 2013, 68:7-12.
22. Pugsley M.K., Authier S., Curtis M.J. Principles of safety pharmacology. British Journal of Pharmacology 2008, 154:1382-1399.
23. Pugsley M.K., Dalton J.A., Authier S., Curtis M.J. Safety pharmacology in 2014: New focus on non-cardiac methods and models. Journal of Pharmacological and Toxicological Methods 2014, 70:170-174.
24. Rast G., Weber J., Disch C., Schuck E., Ittrich C., Guth B.D. An integrated platform for simultaneous multi-well field potential recording and Fura-2-based calcium transient ratiometry in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes. Journal of Pharmacological and Toxicological Methods 2015, 75:91-100.
25. Sager P.T., Gintant G., Turner J.R., Pettit S., Stockbridge N. Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium. American Heart Journal 2014, 16:292-300.
26. Sarazan R.D., Kroehle J.P., Main B.W. Left ventricular pressure, contractility and dP/dt(max) in nonclinical drug safety assessment studies. Journal of Pharmacological and Toxicological Methods 2012, 66:71-78.
27. Tanaka T., Tohyama S., Murata M., Nomura F., Kaneko T., Chen H., et al. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochemical and Biophysical Research Communications 2009, 385:497-502.
28. Ten Tusscher K.H.W.J., Panfilov A.V. Alternans and spiral breakup in a human ventricular tissue model. American Journal of Physiology 2006, 291:H1088-H1100.
29. US DEA Schedules of controlled substances: Rescheduling of hydrocodone combination products from Schedule III to Schedule II. Federal Register 2014, 79:49661-49682.
30. US DEA Drugs of abuse (2011 edition). A DEA resource guide 2014, US Department of Justice, (http://www.dea.gov/pr/multimedia-library/publications/drug_of_abuse.pdf).
31. US DEA Diversion Control Aggregate production quota history for selected substances http://www.deadiversion.usdoj.gov/quotas/quota_history.pdf.
32. US FDA ICHS7A: Safety pharmacology studies for human pharmaceuticals. Federal Register 2001, 66:36791-36792.
33. US FDA Guidance for industry and review staff nonclinical safety evaluation of reformulated drug products and products intended for administration by an alternate route Available at:. http://www.fda.gov/cder/guidance/index.html.
34. Wallis R., Gharanei M., Maddock H.L. Predictivity of in vitro non-clinical cardiac contractility assays for effects in humans - A literature search. Journal of Pharmacological and Toxicological Methods 2015, 75:62-69.
35. Williams G., Mirams G.R. A web portal for in-silico action potential predictions. Journal of Pharmacological and Toxicological Methods 2015, 75:10-16.
36. Xing G., Lu J., Hu M., Wang S., Zhao L., Zheng W., Schofield J., Oldman K., Adkins D., Yu H., Platz S., Ren J., Skinner M. Effects of group housing on ECG assessment in conscious cynomolgus monkeys. Journal of Pharmacological and Toxicological Methods 2015, 75:44-51.